Pancreatic cancer has the worst prognosis among all cancers. Cancer screening of body
fluids may improve the survival time prognosis of patients, who are often diagnosed too late …

The tumor microenvironment plays an important role in the initiation and progression of
pancreatic adenocarcinoma (PDAC). In this systematic review, we provide an overview of …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC), which represents
approximately 90% of all pancreatic cancers, is an extremely aggressive and lethal disease …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes of cancer-
related deaths worldwide, accounting for 90% of primary pancreatic tumors with an average …

Pancreatic cancer (PC) has a poor prognosis due to the lack of effective molecular
biomarkers for early diagnosis. Recent studies have investigated the use of exosomal …

Pancreatic ductal adenocarcinoma (PDAC) is known as a highly aggressive malignant
disease. Prognosis for patients is notoriously poor, despite improvements in surgical …

Pancreatic ductal adenocarcinoma (PDAC) is an intractable cancer and a leading cause of
cancer deaths worldwide. Over 90% of patients die within 1 year of diagnosis. Deaths from …

Breast cancer remains a major global health challenge, demanding better diagnostic tools.
Traditional methods like mammography have limitations, highlighting the need for specific …

Background Extensive extracellular matrix (ECM) remodeling is a hallmark of metastatic
pancreatic ductal adenocarcinoma (mPDA). We investigated fragments of collagen types III …

Purpose: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy
demonstrating aberrant and progressive expression of mucins. The contribution of individual …